243 related articles for article (PubMed ID: 19262378)
1. Genetic basis for idiosyncratic reactions to antiepileptic drugs.
Franciotta D; Kwan P; Perucca E
Curr Opin Neurol; 2009 Apr; 22(2):144-9. PubMed ID: 19262378
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
3. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
5. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
Neuman MG; Cohen L; Nanau RM; Hwang PA
Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
[No Abstract] [Full Text] [Related]
9. Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.
Israel S; Maggio N; Ekstein D; Zaid H; Firer M; Bederovsky Y; Noyman I; Gandelman-Marton R; Blatt I; Brautbar C; Marom E; Nahlieli Dil D; Berman E; Sabag D; Ingber A; Eyal S
Epilepsia; 2016 Oct; 57(10):e205-e209. PubMed ID: 27527795
[TBL] [Abstract][Full Text] [Related]
10. The HLA-B*15:02 polymorphism and Tegretol
Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
12. Do no harm--but first we need to know more: the case of adverse drug reactions with antiepileptic drugs.
Singh G
Neurol India; 2011; 59(1):53-8. PubMed ID: 21339660
[TBL] [Abstract][Full Text] [Related]
13. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
14. Hepatic toxicity of antiepileptic drugs: a review.
Gram L; Bentsen KD
Acta Neurol Scand Suppl; 1983; 97():81-90. PubMed ID: 6424399
[TBL] [Abstract][Full Text] [Related]
15. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
16. Stratification of the risk of serious allergic cutaneous reactions with therapeutic management of trigeminal neuralgia.
Shakib K; Sinanan M
Br J Oral Maxillofac Surg; 2011 Apr; 49(3):235-6. PubMed ID: 20430493
[TBL] [Abstract][Full Text] [Related]
17. Idiosyncratic adverse reactions to antiepileptic drugs.
Zaccara G; Franciotta D; Perucca E
Epilepsia; 2007 Jul; 48(7):1223-44. PubMed ID: 17386054
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
[TBL] [Abstract][Full Text] [Related]
19. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
[TBL] [Abstract][Full Text] [Related]
20. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.
Wang Q; Zhou JQ; Zhou LM; Chen ZY; Fang ZY; Chen SD; Yang LB; Cai XD; Dai QL; Hong H; Wang HX
Seizure; 2011 Jul; 20(6):446-8. PubMed ID: 21397523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]